Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid Nanoparticle Co-Delivery of mRNA and a Small Molecule Drug for Oral Cancer Chemoimmunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transient T cell therapies.

Advances in pharmacology (San Diego, Calif.)·2026
Same author

Matrix mechanics couple contractility to metabolic adaptation in cancer cells.

Acta biomaterialia·2026
Same author

Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis.

Nature communications·2026
Same author

Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors.

Bioengineering & translational medicine·2026

Related Experiment Video

Updated: Apr 27, 2026

A Microfluidic Device for Quantifying Bacterial Chemotaxis in Stable Concentration Gradients
09:28

A Microfluidic Device for Quantifying Bacterial Chemotaxis in Stable Concentration Gradients

Published on: April 19, 2010

11.6K

A microfluidic device to select for cells based on chemotactic phenotype.

Saumendra Bajpai, Michael J Mitchell, Michael R King

    Technology
    |July 8, 2014
    PubMed
    Summary

    This study introduces a novel device for cancer research. It isolates aggressive cells using chemotaxis, enabling independent study of metastasis drivers.

    Area of Science:

    • Biomedical Engineering
    • Cell Biology
    • Cancer Research

    Background:

    • Metastasis research often relies on population-level molecular analysis.
    • This approach can obscure critical cellular differences driving disease progression.
    • Identifying specific metastatic cell signatures remains a challenge.

    Purpose of the Study:

    • To develop a method for isolating aggressive cancer cells.
    • To enable the study of individual cell behaviors related to metastasis.
    • To overcome limitations of ensemble-averaged measurements in biomarker discovery.

    Main Methods:

    • A device was engineered to select cells based on chemotactic behavior.
    • Cellular response to chemical gradients was utilized for isolation.

    More Related Videos

    An All-on-chip Method for Rapid Neutrophil Chemotaxis Analysis Directly from a Drop of Blood
    07:21

    An All-on-chip Method for Rapid Neutrophil Chemotaxis Analysis Directly from a Drop of Blood

    Published on: June 23, 2017

    16.4K
    Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood
    10:13

    Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood

    Published on: June 3, 2014

    10.9K

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    A Microfluidic Device for Quantifying Bacterial Chemotaxis in Stable Concentration Gradients
    09:28

    A Microfluidic Device for Quantifying Bacterial Chemotaxis in Stable Concentration Gradients

    Published on: April 19, 2010

    11.6K
    An All-on-chip Method for Rapid Neutrophil Chemotaxis Analysis Directly from a Drop of Blood
    07:21

    An All-on-chip Method for Rapid Neutrophil Chemotaxis Analysis Directly from a Drop of Blood

    Published on: June 23, 2017

    16.4K
    Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood
    10:13

    Microfluidic Platform for Measuring Neutrophil Chemotaxis from Unprocessed Whole Blood

    Published on: June 3, 2014

    10.9K
  • This method bypasses traditional molecular screening.

    • Main Results:

    • The device successfully isolates cells exhibiting specific chemotactic properties.
    • This allows for the study of highly aggressive cell populations.
    • Individual cell behavior can be analyzed independently of the bulk population.

    Conclusions:

    • Chemotaxis-based cell selection offers a new paradigm for metastasis research.
    • This technique facilitates the study of aggressive cell phenotypes.
    • It provides a powerful tool for identifying novel metastasis biomarkers.